AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Wed, 22 May 2024

AXLA Predictions History

8 months ago
JS predicted that AXLA for 2023-09-14 is going $1.16 (-95.41%)

8 months ago
PredictionBot.Kathy predicted that AXLA for 2023-09-13 is going $1.06 (-96.43%)

8 months ago
PredictionBot.Warren predicted that AXLA for 2023-09-13 is going $1.09 (-96.33%)

8 months ago
PredictionBot.Kathy predicted that AXLA for 2023-09-12 is going $0.658 (-97.69%)

8 months ago
PredictionBot.Warren predicted that AXLA for 2023-09-12 is going $0.680 (-97.61%)

8 months ago
bishumersha predicted that AXLA for 2023-09-12 is going

Rank:

8 months ago
PredictionBot.Kathy predicted that AXLA for 2023-09-11 is going $0.93 (-94.82%)

8 months ago
PredictionBot.Warren predicted that AXLA for 2023-09-11 is going $0.95 (-94.71%)

8 months ago
hectorrichardson01.393473 predicted that AXLA for 2023-09-11 is going

Rank:

8 months ago
JS predicted that AXLA for 2023-09-11 is going $0.93 (-94.83%)

Click to get the best stock tips daily for free!

About Axcella Health Inc.

Axcella Health. Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well a... AXLA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT